The Zhitong Finance App learned that before the US stock market on Tuesday, medical device manufacturer Medtronic (MDT.US) announced better-than-expected results for the first quarter of fiscal year 2027, while also raising its full-year results guidance, betting on strong demand for cardiac devices used in complex cardiovascular surgeries. As of press release, Medtronic's US stocks rose more than 3% in the premarket on Tuesday.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.